This is less a demand shock than a rerating problem: the market had already priced in a self-help story, so an in-line guide reset the bar from “AI inflection” to “prove it.” In software names with high gross margins and long duration cash flows, 1 quarter of decent execution rarely matters; what matters is whether forward revenue estimates can keep moving up, and here the near-term setup looks like flat-to-down revisions. That usually means the first reaction is only the beginning, because holders who bought the multiple expansion are forced to de-risk over the next 2-6 weeks.

The bigger second-order effect is competitive. If Zoom cannot convert AI usage into measurable ARPU and retention, enterprise buyers will keep consolidating spend into suite vendors like MSFT Teams and, to a lesser extent, Cisco/Webex or RNG, where collaboration is a feature inside a broader workflow bundle. That is a bad trade for Zoom because the company loses pricing power exactly when procurement teams are pushing for platform discounts; the AI product may drive engagement, but unless it shows up in revenue disclosures, it risks becoming a marketing lever rather than a margin lever.

Contrarian view: the core business may be more durable than the selloff implies, and the fastest enterprise growth in years suggests the base is not deteriorating. The market may be underweight the optionality in AI add-ons if customer counts are leading indicator for a larger revenue ramp over the next 6-18 months. The thesis breaks if the next quarter shows sustained >7-8% enterprise growth, a clearer AI monetization metric, and another upward FY revision; absent that, the path of least resistance is lower on post-earnings drift and multiple compression.